SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?


To: Doug Bean who wrote (1555)12/22/1999 12:13:00 PM
From: vestor  Read Replies (1) | Respond to of 1837
 
We need that 1.25 dosage. I know of three individuals wanting to move to Cenestin when the 1.25 dosage arrives. I suspect a nice pop in sales will occur when approval is given. My contact tells me that APRI is selling very well and that purchases from DRMD has been climbing at a good clip. He says after 1/1/2000 APRI sales should increase further due to some major formularies kicking in that encourage the generic form.